These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 14719995)

  • 1. Adverse effects of beta-agonists: are they clinically relevant?
    Abramson MJ; Walters J; Walters EH
    Am J Respir Med; 2003; 2(4):287-97. PubMed ID: 14719995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Cates MJ
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular treatment with formoterol for chronic asthma: serious adverse events.
    Cates CJ; Cates MJ; Lasserson TJ
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006923. PubMed ID: 18843738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006924. PubMed ID: 19370661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma treatment: inhaled beta-agonists.
    Sears MR
    Can Respir J; 1998; 5 Suppl A():54A-9A. PubMed ID: 9753519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
    Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE
    Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
    Bisgaard H
    Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Shah L; Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.
    Taylor DR; Town GI; Herbison GP; Boothman-Burrell D; Flannery EM; Hancox B; Harré E; Laubscher K; Linscott V; Ramsay CM; Richards G
    Thorax; 1998 Sep; 53(9):744-52. PubMed ID: 10319056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of long-acting beta2-adrenoceptor agonism.
    Lipworth BJ
    Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.
    Habbick B; Baker MJ; McNutt M; Cockcroft DW
    CMAJ; 1995 Nov; 153(10):1437-43. PubMed ID: 7585370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response of inhaled drugs in asthma. An update.
    Clark DJ; Lipworth BJ
    Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.